Takashi Yamada

Dr. Takashi Yamada

Department of Physical Therapy, Sapporo Medical University, Sapporo, Japan
orcid

Research Focus & Metrics

Academic Career Length

34Years (1993-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 April 2010 in European Journal of Applied Physiology
Verified
Journal Article
Closed access
NPNicolas Place
Nicolas Place
Takashi YamadaTakashi Yamada
Takashi Yamada
JBJoseph Bruton
Joseph Bruton
Håkan WesterbladHåkan Westerblad
Håkan Westerblad

20 March 2016 in The Journal of Physiology
Verified
Journal Article
Closed access
PDF file
ACArthur J. Cheng
Arthur J. Cheng
Takashi YamadaTakashi Yamada
Takashi Yamada
DRDilson E. Rassier
Dilson E. Rassier
DADaniel C Andersson
Daniel C Andersson
Håkan WesterbladHåkan Westerblad
Håkan Westerblad
JLJohanna T. Lanner
Johanna T. Lanner

2 January 2008 in The Journal of Physiology
Verified
Journal Article
Closed access
JBJoseph Bruton
Joseph Bruton
NPNicolas Place
Nicolas Place
Takashi YamadaTakashi Yamada
Takashi Yamada
JSJosé P. Silva
José P. Silva
FAFrancisco H. Andrade
Francisco H. Andrade
Håkan WesterbladHåkan Westerblad
Håkan Westerblad

30 March 2011 in The Journal of Physiology
Verified
Journal Article
Closed access
DADaniel C Andersson
Daniel C Andersson
JFJérémy Fauconnier
Jérémy Fauconnier
Takashi YamadaTakashi Yamada
Takashi Yamada
ALAlain Lacampagne
Alain Lacampagne
SZShi‐Jin Zhang
Shi‐Jin Zhang
Håkan WesterbladHåkan Westerblad
Håkan Westerblad

16 October 2009 in The FASEB Journal
Verified
Journal Article
Open access
PDF file
CGCecilia Grundtman
Cecilia Grundtman
JBJoseph Bruton
Joseph Bruton
Takashi YamadaTakashi Yamada
Takashi Yamada
TÖTherese Östberg
Therese Östberg
DPDavid S. Pisetsky
David S. Pisetsky
Håkan WesterbladHåkan Westerblad
Håkan Westerblad
Idiopathic inflammatory myopathies (IIMs) are heterogeneous rheumatic disorders of unknown cause characterized by muscle weakness, inflammatory cell infiltrates, and major histocompatibility complex (MHC) class I expression on muscle fibers. The nonhistone nuclear protein alarmin high‐mobility group box 1 protein (HMGB1) has been detected extranuclearly in muscle biopsies from patients with IIMs. We hypothesize that HMGB1 has a central role in the cause of muscle weakness, particularly in the early phases of IIMs. Experiments were performed on skeletal muscle fibers isolated from adult mice, which were exposed to recombinant interferon (IFN)‐γ or HMGB1. The myoplasmic free [Ca 2+ ] was measured. Stimulation with IFN‐γ resulted in increased HMGB1 expression in muscle nuclei and the myoplasm. Exposure to HMGB1 induced a reversible up‐regulation of MHC class I in the muscle fibers. However, HMGB1 exposure caused an irreversible decrease in Ca 2+ release from the sarcoplasmic reticulum during fatigue, induced by repeated tetanic contractions. HMGB1 and MHC class I were frequently colocalized in the myoplasm of muscle fibers in muscle biopsies from patients with early IIMs. However, HMGB1‐expressing fibers outnumbered fibers expressing MHC class I. Our data indicate that HMGB1 could be an early inducer of skeletal muscle dysfunction in IIMs.—Grundtman, C., Bruton, J., Yamada, T., Östberg, T., Pisetsky, D. S., Harris, H. E., Andersson, U., Lundberg, I. E., Westerblad, H. Effects of HMGB1 on in vitro responses of isolated muscle fibers and functional aspects in skeletal muscles of idiopathic inflammatory myopathies. FASEB J . 24, 570–578 (2010). www.fasebj.org

29 October 2010 in The Journal of Physiology
Verified
Journal Article
Closed access
JBJoseph Bruton
Joseph Bruton
JAJan Aydin
Jan Aydin
Takashi YamadaTakashi Yamada
Takashi Yamada
ISIrina G. Shabalina
Irina G. Shabalina
NINiklas Ivarsson
Niklas Ivarsson
Håkan WesterbladHåkan Westerblad
Håkan Westerblad